BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression
Crossref DOI link: https://doi.org/10.1007/s11010-022-04389-1
Published Online: 2022-02-19
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Jing
Guo, Zhe
Yuan, Shuang
Li, Heli
Text and Data Mining valid from 2022-02-19
Version of Record valid from 2022-02-19
Article History
Received: 14 November 2021
Accepted: 2 February 2022
First Online: 19 February 2022
Declarations
:
: No conflict of interest.
: Not applicable.